ArticleMetabolites2026

A Pilot Serum Metabolomics Reveals Mitochondrial Dysfunction and Identifies Methylguanidine as a Potential Diagnostic Biomarker for ATAAD with Mesenteric Malperfusion Syndrome.

Junyi Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.